(Q53258171)

English

How frequent are invasive therapies required in patients receiving tamsulosin for benign prostatic hyperplasia? A retrospective long-term study.

scientific article published in February 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16563136

How frequent are invasive therapies required in patients receiving tamsulosin for benign prostatic hyperplasia? A retrospective long-term study. (English)

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16563136

invasive therapy

1 reference

based on heuristic

inferred from title

2

object named as

Yukio Homma

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16563136

author name string

Kazuki Kawabe

1

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16563136

Kiyoshi Kubota

3

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16563136

Takashi Sozu

4

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16563136

TAMSULOSIN LONG-TERM STUDY GROUP*

5

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16563136

publication date

1 February 2006

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16563136

International Journal of Urology

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16563136

13

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16563136

127-131

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16563136

2

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16563136

Long-term safety and efficacy of tamsulosin for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2006.01245.X

21 January 2018

Long-term treatment outcome of tamsulosin for benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2006.01245.X

21 January 2018

Estimate criteria for efficacy of treatment in benign prostatic hyperplasia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2006.01245.X

21 January 2018

Long-Term Risk Of Re-Treatment Of Patients Using α-Blockers For Lower Urinary Tract Symptoms

1 reference

https://api.crossref.org/works/10.1111%2FJ.1442-2042.2006.01245.X

21 January 2018

Identifiers

10.1111/J.1442-2042.2006.01245.X

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16563136

1 reference

Europe PubMed Central

12 May 2018

http://europepmc.org/abstract/MED/16563136

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53258171&oldid=1978491680"